Gynecologic Oncology DART

Faculty Members: 

Alessandro Santin, MD

Peter Schwartz, MD

Support Staff:

Clinical Research Coordinators

Lisa Baker
Martha Luther

Regulatory Coordinators
Michelle King
Kay Debski


  • To build a multidisciplinary research program interacting with the research programs of the Yale Cancer Center (YCC) and taking advantage of the shared  YCC resources.
  • To develop a robust clinical/translational research program with high clinical trial accrual and impact on patient care.

Goals for 2016: 

  1. To apply new nanotechnology solutions to the therapy of ovarian cancer
  2. To apply WES and WGS solutions to uterine cancers and evaluate the impact of racial disparity in biologically aggressive USC and CS
  3. To evaluate the therapeutic effect of a novel “prime and pull” vaccination strategy and resulting immune responses in women with pre-cancerous cervical intraepithelial neoplasia (CIN 2-3)
  4. To evaluate the therapeutic effect of dual BET/PIK3CA Targeting in ovarian and endometrial cancer cell lines